The final draft of the manuscript was reviewed and approved by all participants. Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is a rare disease. As a consequence of this, there are no ...
ASH 2024 featured practice-changing studies in lymphoid malignancies, including tafasitamab’s impact in FL, ibrutinib’s OS benefit in MCL, and promising epcoritamab data in CLL.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback